RankingsPricing
  1. JP-listed companies
  2. WAKAMOTO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Repurchases of common stock

WAKAMOTO PHARMACEUTICAL CO.,LTD.【JP:4512】

Market cap
¥10.4B
P/E ratio
51.9x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRepurchases of common stock (Million JPY)YoY (%)
Mar 31, 2025-0+163.89%
Mar 31, 2024-0-52.00%
Mar 31, 2023-0+20.97%
Mar 31, 2022-0-26.19%
Mar 31, 2021-0+27.27%
Mar 31, 2020-0-39.45%
Mar 31, 2019-0-96.99%
Mar 31, 2018-4+18.56%
Mar 31, 2017-3-10.08%
Mar 31, 2016-3-38.55%
Mar 31, 2015-6

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)